Key Takeaways
- Ahead of Oracle’s Q1 FY2027 earnings release scheduled for September 10, Mizuho maintains its Outperform rating with a $320 price target
- Currently trading at $158.78, Oracle shares have declined 54% from their 52-week peak of $345.72; InvestingPro identifies the stock as undervalued
- Wall Street anticipates 34% revenue expansion for fiscal 2027, primarily fueled by Oracle Cloud Infrastructure momentum
- Virginia Retirement Systems initiated a $34 million position in Oracle during Q2; institutional ownership represents 42.44% of shares outstanding
- Consensus among 40 analysts suggests “Moderate Buy” with an average price target of $261.68
As Oracle (ORCL) approaches its fiscal Q1 2027 earnings announcement scheduled for September 10, investor attention intensifies around what the results might reveal. Shares are currently changing hands at $158.78, representing a significant decline from the 52-week peak of $345.72.
Investment firm Mizuho has maintained its Outperform stance on the stock while reaffirming a $320 price objective. The analyst firm anticipates Oracle will surpass Street expectations, with Oracle Cloud Infrastructure positioned as the primary growth catalyst.
The firm projects roughly 1 gigawatt of additional OCI capacity to be deployed during Q1. This figure is notable when measured against the approximately 1.2 gigawatts brought online throughout the entirety of fiscal 2026, signaling an accelerated expansion pace.
Wall Street consensus calls for 34% revenue expansion in fiscal 2027. Given that Oracle delivered 17.35% revenue growth over the trailing twelve months, expectations have been elevated substantially.
What to Expect from the Upcoming Report
During its latest quarterly disclosure on June 10, Oracle announced earnings per share of $2.11, exceeding the analyst consensus of $1.96 by $0.15. Total revenue reached $19.18 billion, topping projections of $19.10 billion while marking a 20.6% year-over-year increase.
Management has provided Q1 2027 EPS guidance between $1.72 and $1.76, alongside full-year FY2027 EPS expectations of $8.05. Based on options market activity, traders are anticipating approximately a 10% price swing in either direction post-announcement.
Morgan Stanley has lifted its price objective to $210 while maintaining an Equal Weight stance. Jefferies reduced its target to $290 but preserved its Buy recommendation, expressing reservations regarding data center implementation and capital structure.
Citigroup confirmed its Buy rating in late August. CLSA launched coverage with a Hold designation and $145 target. Among the 40 analysts tracking Oracle, 28 recommend Buy, nine suggest Hold, two rate it Strong Buy, and one advises Sell. The mean price target stands at $261.68.
Recent Institutional Movements
Virginia Retirement Systems established a fresh stake in Oracle throughout Q2, acquiring 232,487 shares with an approximate value of $34.07 million. Multiple additional funds expanded their holdings during the same timeframe.
Institutional investors and hedge funds control 42.44% of Oracle’s shares. Corporate insiders hold 40.90%, although Vice Chairman Jeffrey Henley divested 400,000 shares in late June at an average price of $159.16, reducing his position by half.
Oracle distributes a quarterly dividend of $0.50 per share, translating to $2.00 annually and yielding 1.3%. The current payout ratio sits at 34.31%.
Mizuho noted that market participants might be overlooking advancements in bring-your-own-hyperscaler arrangements and prepaid frameworks, which serve to alleviate balance sheet constraints.
Critical metrics to monitor on September 10 encompass OCI expansion rates, remaining performance obligations, capital expenditure transparency, and any commentary regarding equity issuance connected to the disclosed $20 billion financing initiative.
Mizuho identified the October 28 Investor Day event as the subsequent significant milestone following the earnings announcement.


